|
|
|
Volumn 6, Issue 1, 1997, Pages 31-42
|
|
Quinupristin/dalfopristin (RP 59500, Synercid®). Microbiological and clinical profile of the first parenteral combination of the streptogramin group;Quinupristin/Dalfopristin (RP 59500, Synercid®). Mikrobiologisches und klinisches Profil der ersten parenteralen Substanzkombination aus der Gruppe der Streptogramine
a
|
|
Author keywords
quinupristin dalfopristin; RP 59500; streptogramin; Synercid
|
|
Indexed keywords
AZITHROMYCIN;
CEFTAZIDIME;
CHLORAMPHENICOL;
CIPROFLOXACIN;
CLARITHROMYCIN;
CLINDAMYCIN;
DALFOPRISTIN;
DALFOPRISTIN PLUS QUINUPRISTIN;
ERYTHROMYCIN;
GENTAMICIN;
IMIPENEM;
METRONIDAZOLE;
OXACILLIN;
PENICILLIN G;
PRISTINAMYCIN;
QUINUPRISTIN;
RIFAMPICIN;
STREPTOGRAMIN DERIVATIVE;
TETRACYCLINE;
TOXYCYCLINE;
TRIMETHOPRIM;
UNCLASSIFIED DRUG;
VANCOMYCIN;
VIRGINIAMYCIN M2;
WATER;
ANAEROBIC BACTERIUM;
ANIMAL MODEL;
ANTIBACTERIAL ACTIVITY;
BACTERIAL INFECTION;
BACTERICIDAL ACTIVITY;
CHEMICAL MODIFICATION;
CLINICAL TRIAL;
DRUG HYPERSENSITIVITY;
DRUG MIXTURE;
DRUG SOLUBILITY;
GRAM NEGATIVE BACTERIUM;
GRAM POSITIVE BACTERIUM;
HUMAN;
LEUKOPENIA;
LYMPHOCYTOPENIA;
MULTIDRUG RESISTANCE;
NONHUMAN;
POSTANTIBIOTIC EFFECT;
REVIEW;
STREPTOMYCES;
|
|
EID: 0030958955
PISSN: 09406735
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (8)
|
|
References (101)
|
